Literature DB >> 12021240

IFNs and STATs in innate immunity to microorganisms.

Thomas Decker1, Silvia Stockinger, Marina Karaghiosoff, Mathias Müller, Pavel Kovarik.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12021240      PMCID： PMC150987          DOI： 10.1172/JCI15770

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  61 in total

1.  Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon.

Authors:  R Deonarain; A Alcamí; M Alexiou; M J Dallman; D R Gewert; A C Porter
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Type I IFN modulates innate and specific antiviral immunity.

Authors:  J E Durbin; A Fernandez-Sesma; C K Lee; T D Rao; A B Frey; T M Moran; S Vukmanovic; A García-Sastre; D E Levy
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

3.  Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae.

Authors:  M E Rottenberg; A Gigliotti Rothfuchs; D Gigliotti; M Ceausu; C Une; V Levitsky; H Wigzell
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

4.  p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide.

Authors:  L Navarro; M David
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

Review 5.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

Authors:  C Schindler; J E Darnell
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

Review 6.  Serine phosphorylation of STATs.

Authors:  T Decker; P Kovarik
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

7.  Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies.

Authors:  T Kimura; Y Kadokawa; H Harada; M Matsumoto; M Sato; Y Kashiwazaki; M Tarutani; R S Tan; T Takasugi; T Matsuyama; T W Mak; S Noguchi; T Taniguchi
Journal:  Genes Cells       Date:  1996-01       Impact factor: 1.891

Review 8.  Immune defence in mice lacking type I and/or type II interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; R M Zinkernagel; M Aguet
Journal:  Immunol Rev       Date:  1995-12       Impact factor: 12.988

9.  Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

Authors:  M A Meraz; J M White; K C Sheehan; E A Bach; S J Rodig; A S Dighe; D H Kaplan; J K Riley; A C Greenlund; D Campbell; K Carver-Moore; R N DuBois; R Clark; M Aguet; R D Schreiber
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

10.  Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.

Authors:  J E Durbin; R Hackenmiller; M C Simon; D E Levy
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582
View more
  84 in total

Review 1.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Series introduction. JAK-STAT signaling in human disease.

Authors:  Christian W Schindler
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 3.  Mast cell homeostasis and the JAK-STAT pathway.

Authors:  J K Morales; Y T Falanga; A Depcrynski; J Fernando; J J Ryan
Journal:  Genes Immun       Date:  2010-06-10       Impact factor: 2.676

4.  STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock.

Authors:  Daniela Herzig; Geping Fang; Tracy E Toliver-Kinsky; Yin Guo; Julia Bohannon; Edward R Sherwood
Journal:  Shock       Date:  2012-10       Impact factor: 3.454

5.  Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.

Authors:  Costanza Casiraghi; Ana Citlali Márquez; Iryna Shanina; Marc Steven Horwitz
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

6.  Negative and positive regulation of gene expression by mouse histone deacetylase 1.

Authors:  Gordin Zupkovitz; Julia Tischler; Markus Posch; Iwona Sadzak; Katrin Ramsauer; Gerda Egger; Reinhard Grausenburger; Norbert Schweifer; Susanna Chiocca; Thomas Decker; Christian Seiser
Journal:  Mol Cell Biol       Date:  2006-08-28       Impact factor: 4.272

7.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

8.  Induction of iNOS expression and antimicrobial activity by interferon (IFN)-beta is distinct from IFN-gamma in Burkholderia pseudomallei-infected mouse macrophages.

Authors:  P Utaisincharoen; N Anuntagool; S Arjcharoen; K Limposuwan; P Chaisuriya; S Sirisinha
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

9.  Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.

Authors:  Matteo Rossi; Patrik Castiglioni; Mary-Anne Hartley; Remzi Onur Eren; Florence Prével; Chantal Desponds; Daniel T Utzschneider; Dietmar Zehn; Maria G Cusi; F Matthew Kuhlmann; Stephen M Beverley; Catherine Ronet; Nicolas Fasel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

10.  Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses.

Authors:  Christie Wacher; Marcus Müller; Markus J Hofer; Daniel R Getts; Regina Zabaras; Shalina S Ousman; Fulvia Terenzi; Ganes C Sen; Nicholas J C King; Iain L Campbell
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.